Commodore Capital’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-89,775
| Closed | -$2.85M | – | 36 |
|
2023
Q3 | $2.85M | Buy |
+89,775
| New | +$2.85M | 0.33% | 28 |
|
2021
Q3 | – | Sell |
-17,169
| Closed | -$5.83M | – | 33 |
|
2021
Q2 | $5.83M | Hold |
17,169
| – | – | 2.03% | 21 |
|
2021
Q1 | $6.95M | Buy |
17,169
+10,816
| +170% | +$4.38M | 2.77% | 16 |
|
2020
Q4 | $4.23M | Buy |
+6,353
| New | +$4.23M | 2.3% | 22 |
|